Institutional members access full text with Ovid®

Share this article on:

The use of S100B as a biomarker in subarachnoid hemorrhage: Clarity in its promise and limits*

Laskowitz, Daniel T. MD, MHS; Warner, David S.

doi: 10.1097/CCM.0b013e3181810457
Editorials

Departments of Medicine (Neurology), Anesthesiology, and Neurobiology, Duke University, Durham, NC (Laskowitz)

Departments of Anesthesiology, and Neurobiology, Duke University, Durham, NC (Warner)

Dr. Laskowitz holds a consultancy with Biosite Diagnostics. Dr. Warner has not disclosed any potential conflicts of interest.

© 2008 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins